neoplasm
• most mice develop lung lesions only after long-term (28-32 weeks) administration of doxycycline (dox)
• lung tumors of dox treated mice are invasive lung adenocarcinomas
• regression of tumors is seen after removal of the inducer dox
• lung tumors of dox treated mice are resistant to treatment with erlotinib
|
respiratory system
• most mice develop lung lesions only after long-term (28-32 weeks) administration of doxycycline (dox)
• lung tumors of dox treated mice are invasive lung adenocarcinomas
• regression of tumors is seen after removal of the inducer dox
• lung tumors of dox treated mice are resistant to treatment with erlotinib
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
lung cancer | DOID:1324 |
OMIM:211980 OMIM:608935 OMIM:612571 OMIM:612593 OMIM:614210 |
J:128700 |